Items where authors include "Kacar, M"

Article

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Kacar, M, Cortes-Acevedo, P, Patel, V et al. (8 more authors) (2021) Neutralizing Anti-interferon-γ Autoantibodies: an Ameliorating Factor in COVID-19 Infection? Journal of Clinical Immunology, 41. pp. 1531-1535. ISSN 0271-9142

Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Van Nieuwenhove, E, De Langhe, E, Dooley, J et al. (10 more authors) (2021) Phenotypic analysis of pyrin-associated autoinflammation with neutrophilic dermatosis patients during treatment. Rheumatology. ISSN 1462-0324

Watad, A, Kacar, M, Bragazzi, NL et al. (10 more authors) (2021) Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication. Frontiers in Immunology, 12. p. 610019. ISSN 1664-3224

Lara-Reyna, S, Poulter, JA orcid.org/0000-0003-2048-5693, Vasconcelos, EJR orcid.org/0000-0001-5130-6622 et al. (5 more authors) (2021) Identification of Critical Transcriptomic Signaling Pathways in Patients with H Syndrome and Rosai-Dorfman Disease. Journal of Clinical Immunology, 41 (2). pp. 441-457. ISSN 0271-9142

Pathak, S, Rowczenio, D, Lara-Reyna, S et al. (8 more authors) (2020) Evidence of B Cell Clonality and Investigation Into Properties of the IgM in Patients With Schnitzler Syndrome. Frontiers in Immunology, 11. 569006. ISSN 1664-3224

Kacar, M, Fitton, J orcid.org/0000-0002-7795-8191, Gough, AK et al. (3 more authors) (2020) Mixed results with baricitinib in biological-resistant adult-onset Still’s disease and undifferentiated systemic autoinflammatory disease. RMD Open, 6 (2). e001246. ISSN 2056-5933

Kacar, M, Denman, S and Savic, S orcid.org/0000-0001-7910-0554 (2018) Selective Response to Omalizumab in a Patient With Concomitant ncMCAS and POTS: What Does it Teach us About the Underlying Disease? Journal of Investigational Allergology and Clinical Immunology, 28 (4). pp. 261-263. ISSN 1018-9068